Literature DB >> 20664381

Doctor, should I get this new ovarian cancer test-OVA1?

Carolyn Y Muller1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20664381     DOI： 10.1097/AOG.0b013e3181e934ba

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN： 0029-7844            Impact factor:   7.661


× No keyword cloud information.
  6 in total

1.  Ovarian Cancer Tests and Treatment.

Authors:  Jori S Carter; Levi S Downs
Journal:  Female Patient (Parsippany)       Date:  2011

Review 2.  MALDI Imaging Mass Spectrometry (MALDI-IMS)-application of spatial proteomics for ovarian cancer classification and diagnosis.

Authors:  Johan O R Gustafsson; Martin K Oehler; Andrew Ruszkiewicz; Shaun R McColl; Peter Hoffmann
Journal:  Int J Mol Sci       Date:  2011-01-21       Impact factor: 5.923

3.  Potential markers for detection and monitoring of ovarian cancer.

Authors:  Brandon J D Rein; Sajal Gupta; Rima Dada; Joelle Safi; Chad Michener; Ashok Agarwal
Journal:  J Oncol       Date:  2011-04-11       Impact factor: 4.375

Review 4.  Prediction of the treatment response in ovarian cancer: a ctDNA approach.

Authors:  Mina Sharbatoghli; Somayeh Vafaei; Hamidreza Aboulkheyr Es; Mohsen Asadi-Lari; Mehdi Totonchi; Zahra Madjd
Journal:  J Ovarian Res       Date:  2020-10-19       Impact factor: 4.234

5.  Adnexal masses suspected to be benign treated with laparoscopy.

Authors:  Richard H Demir; Greg J Marchand
Journal:  JSLS       Date:  2012 Jan-Mar       Impact factor: 2.172

6.  Early detection biomarkers for ovarian cancer.

Authors:  Sreeja Sarojini; Ayala Tamir; Heejin Lim; Shihong Li; Shifang Zhang; Andre Goy; Andrew Pecora; K Stephen Suh
Journal:  J Oncol       Date:  2012-12-23       Impact factor: 4.375
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.